Korro Bio Inc. logo

Korro Bio Inc.

KRRO | NASDAQ
Chart Builder DCF Calculator
$9.98
-$0.04 (-0.40%)
At close: Sep 21, 2026, 4:00 PM ET
$10
+$0.02 (+0.20%)
Pre-market: Sep 22, 2026, 8:24 AM ET

Market Data

Market Cap
$99.33M
Enterprise Value
$26.51M
Beta
2.25
Average Volume
161.89K
Shares Outstanding (Diluted)
17.62M
Shares Change YoY
87.62%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US5009461089

Price Performance

Price Change 1M
-24.3%
Price Change 3M
-27.2%
Price Change 6M
-8.6%
Price Change YTD
24.0%
Price Change 1Y
-70.8%
Price Change 3Y
-47.6%
Price Change 5Y
-97.3%
1M CAGR (ann.)
-24.7%
1Y CAGR (ann.)
-70.0%
5Y CAGR (ann.)
-51.0%
All-Time CAGR
-45.5%

Valuation

PE Ratio
-1.00
Forward PE
N/A
PEG Ratio
0.07
Forward PEG
0.12
PS Ratio
41.70
Forward PS
189.20
PB Ratio
0.96
P/FCF Ratio
-1.18
P/Adj. FCF Ratio
-1.05
P/OCF Ratio
-2.59
EV/Sales
11.13
EV/EBIT
-0.36
EV/EBITDA
-0.38
EV/FCF
-0.31
Earnings Yield
-100.3%
FCF Yield
-84.9%
Adj. FCF Yield
-95.2%

Financial Health

Net Cash
$72.82M
Total Debt
$42.21M
Cash & Short-Term Investments
$115.04M
Total Assets
$163.45M
Current Ratio
9.55
Quick Ratio
9.55
Debt / Equity Ratio
0.41
Debt / EBITDA
-0.60
Debt / FCF
-0.50
OCF / Debt
-1.99
Interest Coverage
0.00
Altman Z-Score
-3.30
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
72.8%
Operating Profit Margin
-3176.6%
EBITDA Margin
-3019.2%
Net Profit Margin
-4477.1%
FCF Margin
-3541.6%
Adj. FCF Margin
-3971.3%
SBC / Revenue
315.1%
SBC Impact (per share)
-12.1%

Returns

Return on Assets
-65.3%
Return on Equity
-114.3%
Return on Invested Capital
-49.2%
Return on Capital Employed
-50.2%
Return on Tangible Assets
-65.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
41.2%
Revenue CAGR 5Y
-41.7%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
8.5%
EPS CAGR 5Y
70.0%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
13.2%
FCF CAGR 5Y
-6.0%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
12
EPS Growth Next 3Y
18.3%
Revenue Growth Next 3Y
89.3%
Earnings Date
Nov 10, 2026
EPS Estimate (next Q)
-$1.25
EPS Growth Est (next Q)
-35.0%
Revenue Est (next Q)
$187.5K
Revenue Growth Est (next Q)
-82.8%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$15
Price Target Upside
50.3%

Cash Flow

Operating Cash Flow
$-84.02M
Free Cash Flow
$-84.36M
Adj. Free Cash Flow
$-94.6M
FCF Per Share
-$3.87
OCF Per Share
-$3.86
OCF/S Ratio
-2852.6%

Income Statement

Revenue
$2.38M
Gross Profit
$1.35M
Operating Income
$-75.67M
EBITDA
$-70.62M
Net Income
$-106.64M
EPS (Diluted)
-$10.01
Revenue / Employee
$41.79K
Profit / Employee
$-1.87M
Employees
57

© 2026 bestshares.com. All rights reserved.